Correlation Between Elanco Animal and China Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elanco Animal and China Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elanco Animal and China Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elanco Animal Health and China Pharma Holdings, you can compare the effects of market volatilities on Elanco Animal and China Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elanco Animal with a short position of China Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elanco Animal and China Pharma.

Diversification Opportunities for Elanco Animal and China Pharma

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Elanco and China is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Elanco Animal Health and China Pharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Pharma Holdings and Elanco Animal is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elanco Animal Health are associated (or correlated) with China Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Pharma Holdings has no effect on the direction of Elanco Animal i.e., Elanco Animal and China Pharma go up and down completely randomly.

Pair Corralation between Elanco Animal and China Pharma

Given the investment horizon of 90 days Elanco Animal Health is expected to generate 0.34 times more return on investment than China Pharma. However, Elanco Animal Health is 2.92 times less risky than China Pharma. It trades about 0.22 of its potential returns per unit of risk. China Pharma Holdings is currently generating about -0.43 per unit of risk. If you would invest  1,700  in Elanco Animal Health on March 21, 2024 and sell it today you would earn a total of  116.00  from holding Elanco Animal Health or generate 6.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Elanco Animal Health  vs.  China Pharma Holdings

 Performance 
       Timeline  
Elanco Animal Health 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Elanco Animal Health are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Elanco Animal displayed solid returns over the last few months and may actually be approaching a breakup point.
China Pharma Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days China Pharma Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's technical indicators remain fairly strong which may send shares a bit higher in July 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Elanco Animal and China Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elanco Animal and China Pharma

The main advantage of trading using opposite Elanco Animal and China Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elanco Animal position performs unexpectedly, China Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Pharma will offset losses from the drop in China Pharma's long position.
The idea behind Elanco Animal Health and China Pharma Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios